MiMedx acquires Sanara MedTech: $33 cash + 0.4735 shares per share; termination fees corrected

Sanara MedTech Inc.

Each Sanara share to receive $33.00 cash plus 0.4735 MiMedx shares (value ~$2.00) for ~$35.00 total consideration.
Amendment corrects termination fees: Sanara pays $9,660,336; MiMedx pays $22,540,785.
Specified stockholders holding ~38.9% of voting power agreed to vote for the merger.
Merger subject to stockholder approval, HSR clearance, and S-4 effectiveness; closing by July 29, 2027.
Board unanimously recommends the deal; no financing condition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.